Somewhat Positive Press Coverage Somewhat Unlikely to Impact Marrone Bio Innovations (MBII) Share Price

Media headlines about Marrone Bio Innovations (NASDAQ:MBII) have trended somewhat positive recently, Accern reports. The research group identifies negative and positive media coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Marrone Bio Innovations earned a news impact score of 0.20 on Accern’s scale. Accern also gave news stories about the basic materials company an impact score of 44.8121500459465 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

Several equities analysts have issued reports on the company. ValuEngine downgraded Marrone Bio Innovations from a “sell” rating to a “strong sell” rating in a research report on Friday, September 1st. HC Wainwright set a $4.00 target price on Marrone Bio Innovations and gave the stock a “buy” rating in a research report on Thursday. One analyst has rated the stock with a sell rating, three have assigned a hold rating and one has given a buy rating to the stock. Marrone Bio Innovations currently has a consensus rating of “Hold” and an average price target of $2.50.

Marrone Bio Innovations (NASDAQ:MBII) traded up $0.02 during trading hours on Monday, reaching $1.08. The company’s stock had a trading volume of 86,400 shares, compared to its average volume of 95,570. Marrone Bio Innovations has a 1 year low of $0.85 and a 1 year high of $2.45. The company has a current ratio of 0.69, a quick ratio of 0.36 and a debt-to-equity ratio of -1.14. The firm has a market capitalization of $33.86, a PE ratio of -0.94 and a beta of 0.31.

TRADEMARK VIOLATION WARNING: This report was first published by Community Financial News and is owned by of Community Financial News. If you are reading this report on another website, it was illegally stolen and reposted in violation of United States and international trademark and copyright laws. The legal version of this report can be read at https://www.com-unik.info/2017/12/25/somewhat-positive-press-coverage-somewhat-unlikely-to-impact-marrone-bio-innovations-mbii-share-price.html.

Marrone Bio Innovations Company Profile

Marrone Bio Innovations, Inc offers bio-based pest management and plant health products. The Company’s bio-based products include naturally occurring microorganisms, such as bacteria, fungi and plant extracts. It sells its products to crop protection market. Its four crop protection products include Regalia, Grandevo, Venerate and Majestene.

Insider Buying and Selling by Quarter for Marrone Bio Innovations (NASDAQ:MBII)

Receive News & Ratings for Marrone Bio Innovations Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marrone Bio Innovations and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit